However, a substantial number of breast tumors assigned to the ERBB2 subtype lacks ERBB2 protein expression and/or ERBB2 gene amplification [14,15] and ERBB2-positive cancers that express estrogen receptor (ER) fall into the luminal subtypes [11,13,16]. Here, ESR1 is linked to cancer.